Skip to main content
BrainCited

Vitamin E Age-Related Cognitive Decline

C

High-dose vitamin E may slow functional decline in moderate Alzheimer's disease (TEAM-AD trial). Results are mixed for cognitive decline prevention in healthy populations.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dvitamin\u002De\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

結論

High-dose vitamin E may slow functional decline in moderate Alzheimer's disease (TEAM-AD trial). Results are mixed for cognitive decline prevention in healthy populations.

Key Study Findings

Systematic Review n=80488
Vitamin E and cognitive function: A systematic review of clinical evidence.
Dose: None vs: None Outcome: cognitive function / cognitive impairment 効果: None None

対象集団: participants from 43 clinical studies (2012-2022)

Review
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Dose: Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d vs: None Outcome: Cognitive decline in AD 効果: None None

対象集団: Alzheimer's disease patients

Observational Study n=2713 Open-label
Non-linear association between dietary fiber intake and cognitive function mediated by vitamin E: a cross-sectional …
Dose: Inflection at 29.65 g/day (DSST), 22.65 g/day (composite) vs: Cross-sectional fiber intake groups Outcome: Cognitive function composite z-scores (DSST, AFT, CERAD) 効果: β=0.18 per unit fiber below inflection <0.0001

対象集団: NHANES adults aged ≥60 years (2011-2014)

Review
The Role of Vitamins in Neurodegeneration: A Brief Review of Mechanisms, Clinical Evidence, and Therapeutic …
Dose: None vs: None Outcome: None 効果: None None

対象集団: Review of vitamins in neurodegeneration

Review
Bioactive compounds and dietary patterns in Alzheimer's disease.
Dose: None vs: None Outcome: AD progression and cognitive decline 効果: None None

対象集団: Elderly with or at risk of Alzheimer's disease (review)

Meta-Analysis
Associations between Diet and Cognitive Function in Stroke Survivors: A Systematic Review and Meta-analysis.
Dose: None vs: Standard care or placebo Outcome: Global cognition in stroke survivors 効果: SMD=0.62 (energy-protein); SMD=-0.40 (B-vitamins) 0.009 (protein); 0.02 (B-vit)

対象集団: Adult stroke survivors (20 trials + 14 observational)

Key Statistics

12

研究数

3000

参加者数

Mixed

C

グレード

Referenced Papers

Journal of Alzheimer's … 2025 3 件の引用
American journal of … 2025
European geriatric medicine 2023 10 件の引用
Nutrients 2022 76 件の引用
Healthcare (Basel, Switzerland) 2021 7 件の引用
Annals of the … 2016 162 件の引用
Alzheimer's & dementia … 2016 62 件の引用
Parkinsonism & related … 2015 100 件の引用
The British journal … 2015 62 件の引用
Nutrition reviews 2014 25 件の引用
Plant foods for … 2013 155 件の引用
Orphanet journal of … 2011 158 件の引用
American family physician 2011
TheScientificWorldJournal 2009 38 件の引用
Clinica chimica acta; … 2006 134 件の引用
Archives of neurology 2002 354 件の引用
The Proceedings of … 2002 191 件の引用
Asia Pacific journal … 2002 24 件の引用
Current opinion in … 1998 30 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
15 mg/day (RDA)
cognitivesupport:
400-800 IU/day

上限量: 1,000 mg/day (1,500 IU natural / 1,100 IU synthetic)

研究で検討された用量

用量 期間 効果 N
None -- Positive 80488
Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d -- Mixed --
Inflection at 29.65 g/day (DSST), 22.65 g/day (composite) -- Positive 2713
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Positive --
None -- Mixed --

推奨摂取タイミング: With meals containing fat

Safety & Side Effects

報告されている副作用

  • Increased bleeding risk at high doses
  • Nausea and diarrhea
  • Fatigue and weakness
  • Blurred vision

既知の相互作用

  • Anticoagulants (increased bleeding risk)
  • Statins and niacin (may reduce HDL-raising effects)
  • Chemotherapy and radiation (may reduce efficacy)

耐容上限摂取量: 1,000 mg/day (1,500 IU natural / 1,100 IU synthetic)

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Vitamin E help with Age-Related Cognitive Decline?
Based on 12 studies with 3,000 participants, there is limited but promising evidence that Vitamin E may support Age-Related Cognitive Decline management. Our evidence grade is C (Some Evidence).
How much Vitamin E should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 15 mg/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin E?
Reported side effects may include Increased bleeding risk at high doses, Nausea and diarrhea, Fatigue and weakness, Blurred vision. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin E and Age-Related Cognitive Decline?
We rate the evidence as Grade C (Some Evidence). This rating is based on 12 peer-reviewed studies with 3,000 total participants. The overall direction of effect is mixed.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。